SA Rugby confirms Ntlabakanye out of New Zealand tour amid doping case

Asenathi Ntlabakanye will not be considered for the Springboks’ New Zealand tour after returning an adverse analytical finding during a random anti-doping test conducted by the South African Institute for Drug-Free Sport (SAIDS).

He tested positive for a non-performance-enhancing substance, according to a statement by SA Rugby, and will dispute that he has committed an anti-doping violation.

The tighthead prop most recently featured against Australia in the Rugby Championship after making his Bok debut, but will now miss the opportunity to face the All Blacks as the world champions prepare for back-to-back matches in Auckland and Wellington.

According to the statement, the non-performance-enhancing substance for which he tested positive was prescribed by a specialist physician early in 2025 for medical reasons. It was taken with the approval and under the supervision of a medical doctor specifically appointed to manage the medical affairs of professional rugby players.

“Ntlabakanye was transparent in his declarations, acted in good faith, and at all times followed the medical due process as prescribed by the industry,” the statement reads.

 “He relied on the relevant professional medical advice and at no time did he seek to obtain an unfair advantage, nor did he take any medical substance without prior medical authorisation.”

Ntlabakanye will be allowed to focus on defending his case as the Boks continue their Rugby Championship title defence.

SA Rugby stated that neither the player nor his coaches will comment further on the matter until the SAIDS process has been concluded.